Cargando…
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)
The pathogenesis of the adrenocortical cancer (ACC) involves integration of molecular signals and the interplay of different downstream pathways (i.e. IGFII/IGF1R, β-catenin, Wnt, ESR1). This tumor is characterized by limited therapeutic options and unsuccessful treatments. A useful strategy to deve...
Autores principales: | Casaburi, Ivan, Avena, Paola, De Luca, Arianna, Chimento, Adele, Sirianni, Rosa, Malivindi, Rocco, Rago, Vittoria, Fiorillo, Marco, Domanico, Francesco, Campana, Carmela, Cappello, Anna Rita, Sotgia, Federica, Lisanti, Michael P., Pezzi, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694820/ https://www.ncbi.nlm.nih.gov/pubmed/26312764 |
Ejemplares similares
-
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
por: Casaburi, Ivan, et al.
Publicado: (2018) -
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
por: Chimento, Adele, et al.
Publicado: (2015) -
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression
por: Avena, Paola, et al.
Publicado: (2022) -
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway
por: Casaburi, Ivan, et al.
Publicado: (2017) -
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment
por: Nocito, Marta Claudia, et al.
Publicado: (2023)